OSUR Stock — OraSure Technologies Inc

OraSure Technologies Inc (OSUR)

Updated October 16, 2026.

OSUR is a Stock. Total return is 119.3% over the past 39.9 years.

OraSure Technologies is a diagnostics company that develops and distributes rapid diagnostic tests and specimen collection devices, including products for HIV, hepatitis C, COVID-19, and drug testing, along with genomic and microbiome collection systems. The company does not currently distribute to shareholders on a regular basis, though it has made special distributions in the past that may not recur. OraSure appeals to investors seeking exposure to the diagnostics and point-of-care testing sector rather than those focused on regular dividend income.

OSUR performance

Price and return data through 2026-10-16.

Total return is 119.3% over the past 39.9 years. Over the past year its total return — price change plus distributions reinvested — is 18.0%. Its deepest 1-year drawdown was 31.0%.

OSUR key facts

Asset type

Stock

Asset class

Equity

Inception date

11/17/1986

Distribution frequency

None

Last close

$3.61 (as of 2026-10-16)

Market cap

$248,976,743

Average volume

317868.0

Ex-dividend date

01/08/1998

Beta

1.024

Payout ratio

0.0%

Forward P/E

40.0

EPS

$-0.68

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

OSUR risks and drawbacks

The deepest 1-year drawdown on record here is 31.0%.

Who may consider OSUR — and who may not

It is a weaker fit for investors who need monthly cash flow (OSUR does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on OSUR

• All tickers starting with O

Tagged: Healthcare, Dividend.

Frequently asked questions